ZA822554B - Pharmaceutical preparation - Google Patents

Pharmaceutical preparation

Info

Publication number
ZA822554B
ZA822554B ZA822554A ZA822554A ZA822554B ZA 822554 B ZA822554 B ZA 822554B ZA 822554 A ZA822554 A ZA 822554A ZA 822554 A ZA822554 A ZA 822554A ZA 822554 B ZA822554 B ZA 822554B
Authority
ZA
South Africa
Prior art keywords
membrane
polymer
weight
sup
esterification
Prior art date
Application number
ZA822554A
Other languages
English (en)
Inventor
Curt Henry Appelgren
Conny Boerje Bogentoft
Gunnar Harald Ekenved
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of ZA822554B publication Critical patent/ZA822554B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA822554A 1981-04-27 1982-04-14 Pharmaceutical preparation ZA822554B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8102637 1981-04-27

Publications (1)

Publication Number Publication Date
ZA822554B true ZA822554B (en) 1982-12-29

Family

ID=20343682

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA822554A ZA822554B (en) 1981-04-27 1982-04-14 Pharmaceutical preparation

Country Status (15)

Country Link
US (1) US4562061A (no)
EP (1) EP0064485B1 (no)
JP (1) JPS57181008A (no)
AT (1) ATE14379T1 (no)
AU (1) AU553582B2 (no)
CA (1) CA1200762A (no)
DE (1) DE3264867D1 (no)
DK (1) DK184882A (no)
FI (1) FI821422L (no)
GR (1) GR75410B (no)
IE (1) IE52883B1 (no)
NO (1) NO156816C (no)
NZ (1) NZ200386A (no)
PT (1) PT74803B (no)
ZA (1) ZA822554B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2539989B1 (fr) * 1983-01-28 1985-08-09 Sanofi Sa Medicament a liberation programmee associant l'acide acetylsalicylique a la dihydroergotamine
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DE3405378A1 (de) * 1984-02-15 1985-08-22 Röhm GmbH, 6100 Darmstadt Arzneimittelueberzug
IT1196190B (it) * 1984-07-12 1988-11-10 Lisapharma Spa Forma farmaceutica solida orale ad azione sequenziale per la somministrazione di farmaci ad effetto collaterale ulcerogeno
US4867984A (en) * 1984-11-06 1989-09-19 Nagin K. Patel Drug in bead form and process for preparing same
SE458576B (sv) * 1985-06-20 1989-04-17 Lejus Medical Ab Foerfarande foer framstaellning av en guar-gum produkt
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
US5350741A (en) * 1988-07-30 1994-09-27 Kanji Takada Enteric formulations of physiologically active peptides and proteins
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
IE69270B1 (en) * 1989-01-03 1996-08-21 Sterling Winthrop Inc Controlled-release low-dose aspirin
NZ233975A (en) * 1989-08-16 1992-06-25 Sterling Drug Inc Aspirin granules coated with a gastroprotectant
EP0542926B1 (en) * 1990-08-07 1995-02-15 Pfizer Inc. Use of interfacially-polymerized membranes in delivery devices
KR100501022B1 (ko) * 1998-07-28 2005-07-18 다나베 세이야꾸 가부시키가이샤 장내 적소 방출형 제제
FR2821745B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Granules et granules enrobes au gout masque
US6663896B1 (en) * 2001-08-01 2003-12-16 Alvin S. Blum Delayed release aspirin for vascular obstruction prophylaxis
JP4494712B2 (ja) * 2002-11-12 2010-06-30 大日本住友製薬株式会社 マルチプルユニット型徐放性製剤
NL2022082B1 (en) * 2018-11-28 2020-06-25 Univ Free State Transport vessels for facilitating trans-membrane transport

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH283585A (de) * 1950-03-15 1952-06-15 Hoffmann La Roche Zur Herstellung von Tablettenüberzügen geeignetes Gemisch.
US3275518A (en) * 1961-06-07 1966-09-27 Abbott Lab Tablet coating
AT270071B (de) * 1966-08-12 1969-04-10 Roehm & Haas Gmbh Dragierlack für Arzneiformen
US4060598A (en) * 1967-06-28 1977-11-29 Boehringer Mannheim G.M.B.H. Tablets coated with aqueous resin dispersions
DE1792447C3 (de) * 1968-09-04 1978-05-11 Fa. Heinrich Mack Nachf., 7919 Au Oral anwendbares, cytostatisches Mittel
DE2031871C3 (de) * 1970-06-27 1974-06-27 Roehm Gmbh, 6100 Darmstadt Überzugsmasse für Arzneiformen
US3954959A (en) * 1973-03-28 1976-05-04 A/S Alfred Benzon Oral drug preparations
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
US4198402A (en) * 1975-12-17 1980-04-15 Richter Gedeon Vegyeszeti Gyar Rt. Antiphlogistic composition of phenylbutozone and alkali salicylate and method of treatment
US4218433A (en) * 1977-03-03 1980-08-19 Nippon Kayaku Kabushiki Kaisha Constant-rate eluting tablet and method of producing same
GB1584130A (en) * 1978-05-30 1981-02-04 Wyeth John & Brother Ltd Indole derivatives
SE426548B (sv) * 1978-12-05 1983-01-31 Haessle Ab Fast farmaceutisk beredning innehallande en terapeutiskt effektiv hjertglykosid och en polymer
WO1980001242A1 (en) * 1978-12-21 1980-06-26 Sandoz Ag Galenical preparation
SE7813246L (sv) * 1978-12-22 1980-06-23 Haessle Ab Fast farmaceutisk beredning innehallande kroppar med flera ytskikt
IT1207927B (it) * 1979-12-05 1989-06-01 Ivo Rosset Dispositivo per eseguire fotografie panoramiche.
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
NZ200386A (en) 1984-08-24
NO821357L (no) 1982-10-28
PT74803A (en) 1982-05-01
NO156816C (no) 1987-12-02
JPS57181008A (en) 1982-11-08
GR75410B (no) 1984-07-16
FI821422L (fi) 1982-10-28
US4562061A (en) 1985-12-31
FI821422A0 (fi) 1982-04-23
ATE14379T1 (de) 1985-08-15
EP0064485B1 (en) 1985-07-24
AU8298682A (en) 1982-11-04
DK184882A (da) 1982-10-28
CA1200762A (en) 1986-02-18
PT74803B (en) 1985-05-31
IE52883B1 (en) 1988-03-30
AU553582B2 (en) 1986-07-24
DE3264867D1 (en) 1985-08-29
EP0064485A3 (en) 1983-04-13
IE820964L (en) 1982-10-27
NO156816B (no) 1987-08-24
EP0064485A2 (en) 1982-11-10

Similar Documents

Publication Publication Date Title
DE3264867D1 (en) New pharmaceutical preparation
AU594392B2 (en) Pharmaceutical preparation
US4927639A (en) Modified release gemfibrozil composition
NO175618C (no) Fremgangsmåte for fremstilling av en farmasöytisk formulering med kontrollert frigjöring for oral administrering omfattende atskilte enheter omfattende acrivastin eller et salt derav
DE69310461D1 (de) Weiche Kapseln mit Magensaftresistentem Überzug und Verfahren zu ihrer Herstellung
US4925676A (en) Extended release gemfibrozil composition
WO1996029058B1 (en) Peroral composition for controlled release in the lower gastrointestinal tract
AU623731B2 (en) Water dispersible gemfibrozil compositions
US4405597A (en) Medicament capsules for rectal application
JPS57119902A (en) Dispersion stabilizer for suspension polymerization of vinyl compound
JPS57131246A (en) Resin composition
JPS5484020A (en) Composition for coating medicine and method for coating the same
JPS5571750A (en) Polyester composition
RU2001128434A (ru) Маскирующие вкус составы покрытий
JPS5580411A (en) Suspension polymerization of vinyl chloride